Sponsor pipeline

Shanghai Bovax Biotechnology Co., Ltd. clinical trial pipeline

5 active trials 4 recruiting 3 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2		1
Phase 3		3

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04422366	Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in…	Cervical Cancer	Recruiting	2024-06-07
NCT05027776	Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects…	HPV Infections	Recruiting	2024-04-17
NCT06465914	A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV…	Genital Wart	Active, Not Recruiting	2024-12-12
Phase 2
NCT06756269	To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese…	HPV Infection	Recruiting	2025-12-17
Not specified
NCT05371353	Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent…	HPV Infections	Recruiting	2024-04-17

Get alerts when Shanghai Bovax Biotechnology Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.